Joseph S Zakrzewski insider trades: AN2 Therapeutics (ANTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joseph reports to the SEC
and 2 more companies
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | ANTX | ↑ Buy | 2,000 | $1.40 | $3K | Direct | Nov 27, 2024 (0d) |
| Nov 19, 2024 | ANTX | ↑ Buy | 25,000 | $1.00 | $25K | Direct | Nov 20, 2024 (1d) |
| Jan 18, 2024 | ANTX | ↓ Sell | 100,000 | $19.11 | $1.9M | Indirect | Jan 19, 2024 (1d) |
| Dec 7, 2022 | CYT | ↑ Buy | 21,202 | $1.30 | $28K | Direct | Dec 8, 2022 (1d) |
| May 12, 2022 | CYT | ↑ Buy | 743 | $1.61 | $1K | Direct | May 16, 2022 (4d) |
| May 11, 2022 | CYT | ↑ Buy | 50,406 | $1.89 | $95K | Direct | May 12, 2022 (1d) |
| Dec 28, 2021 | CYT | ↑ Buy | 1,100 | $9.91 | $11K | Direct | Dec 28, 2021 (0d) |
| Dec 17, 2021 | CYT | ↑ Buy | 200 | $9.88 | $2K | Direct | Dec 21, 2021 (4d) |
| Dec 15, 2021 | AMRN | ↑ Buy | 12,000 | $3.25 | $39K | Direct | Dec 16, 2021 (1d) |
| Dec 15, 2021 | CYT | ↑ Buy | 3,700 | $10.77 | $40K | Direct | Dec 15, 2021 (0d) |
| Apr 5, 2021 | XLRN | ↓ Sell | 10,000 | $140.73 | $1.4M | Direct | Apr 5, 2021 (0d) |
| Apr 1, 2021 | XLRN | ↓ Sell | 10,000 | $134.64 | $1.3M | Direct | Apr 2, 2021 (1d) |
| Mar 17, 2020 | SGMO | ↑ Buy | 5,000 | $4.99 | $25K | Direct | Mar 19, 2020 (2d) |
| Mar 13, 2020 | SGMO | ↑ Buy | 20,000 | $6.15 | $123K | Direct | Mar 13, 2020 (0d) |
| Jan 3, 2020 | AMRN | ↓ Sell | 300,000 | $20.94 | $6.3M | Direct | Jan 3, 2020 (0d) |
| Dec 16, 2019 | AMRN | ↓ Sell | 100,000 | $25.83 | $2.6M | Direct | Dec 18, 2019 (2d) |
| Jul 5, 2019 | AMRN | ↓ Sell | 100,000 | $23.82 | $2.4M | Direct | Jul 5, 2019 (0d) |
| Jun 18, 2019 | AMRN | ↓ Sell | 100,000 | $19.02 | $1.9M | Direct | Jun 20, 2019 (2d) |
| Jun 14, 2019 | XLRN | ↑ Buy | 5,000 | $38.05 | $190K | Direct | Jun 17, 2019 (3d) |
| Feb 22, 2019 | AMRN | ↓ Sell | 180,625 | $19.90 | $3.6M | Direct | Feb 22, 2019 (0d) |
| Jan 10, 2019 | AMRN | ↓ Sell | 200,000 | $16.98 | $3.4M | Direct | Jan 11, 2019 (1d) |
| Jan 2, 2019 | AMRN | ↓ Sell | 526,500 | $13.07 | $6.9M | Direct | Jan 2, 2019 (0d) |
| Sep 24, 2018 | AMRN | ↓ Sell | 500,000 | $10.60 | $5.3M | Direct | Sep 26, 2018 (2d) |
| Mar 2, 2017 | PODD | ↓ Sell | 40,000 | $46.86 | $1.9M | Direct | Mar 3, 2017 (1d) |
| Dec 30, 2016 | XLRN | ↑ Buy | 4,000 | $25.50 | $102K | Direct | Jan 3, 2017 (4d) |
| Nov 18, 2013 | AMRN | ↑ Buy | 50,777 | $1.54 | $78K | Direct | Nov 18, 2013 (0d) |
| Oct 1, 2012 | AMRN | ↓ Sell | 150,000 | $12.56 | $1.9M | Direct | Oct 3, 2012 (2d) |
| Jul 27, 2012 | AMRN | ↓ Sell | 150,000 | $14.31 | $2.1M | Direct | Jul 30, 2012 (3d) |
| May 29, 2012 | AMRN | ↓ Sell | 150,000 | $11.97 | $1.8M | Direct | May 31, 2012 (2d) |
| Mar 23, 2012 | AMRN | ↓ Sell | 160,000 | $11.59 | $1.9M | Direct | Mar 27, 2012 (4d) |
| Feb 17, 2012 | PODD | ↓ Sell | 5,000 | $20.39 | $102K | Direct | Feb 21, 2012 (4d) |
| Apr 18, 2011 | AMRN | ↓ Sell | 300,000 | $15.76 | $4.7M | Direct | Apr 20, 2011 (2d) |
| Feb 25, 2011 | AMRN | ↓ Sell | 60,000 | $8.16 | $490K | Direct | Feb 28, 2011 (3d) |
| Feb 22, 2011 | AMRN | ↓ Sell | 100,000 | $8.54 | $854K | Direct | Feb 24, 2011 (2d) |
| Nov 19, 2008 | DOVP | ↑ Buy | 772,327 | $0.00 | $2K | Direct | Nov 21, 2008 (2d) |
| Nov 11, 2008 | PODD | ↑ Buy | 5,000 | $4.71 | $24K | Direct | Nov 13, 2008 (2d) |
| Sep 30, 2008 | DOVP | ↑ Buy | 125,000 | $0.04 | $5K | Direct | Oct 8, 2008 (8d) |
| Sep 15, 2008 | DOVP | ↑ Buy | 26,500 | $0.04 | $981 | Direct | Sep 15, 2008 (0d) |
| Sep 9, 2008 | DOVP | ↑ Buy | 59,881 | $0.04 | $2K | Direct | Sep 9, 2008 (0d) |
| Aug 27, 2008 | DOVP | ↑ Buy | 200,000 | $0.04 | $7K | Direct | Sep 2, 2008 (6d) |
| Jul 16, 2008 | DOVP | ↑ Buy | 10,495 | $0.04 | $378 | Direct | Jul 18, 2008 (2d) |
| Jun 30, 2008 | DOVP | ↑ Buy | 76,826 | $0.04 | $3K | Direct | Jul 1, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANTX insiders
Open-market trades in the last 12 months
About Joseph S Zakrzewski's insider trades
Joseph S Zakrzewski is an insider at AN2 Therapeutics (ANTX). Since Jun 30, 2008, Joseph has reported 22 open-market purchases worth $806K and 20 sales worth $52.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (47 filings), option exercises (29 filings), shares returned to the company (3 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.